{"id":73507,"date":"2026-10-23T12:08:20","date_gmt":"2026-10-23T16:08:20","guid":{"rendered":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/novartis-ms-drug-breakthrough-and-tiktoks-multi-gigawatt-compute-push\/73507\/"},"modified":"2026-10-23T12:08:20","modified_gmt":"2026-10-23T16:08:20","slug":"novartis-ms-drug-breakthrough-and-tiktoks-multi-gigawatt-compute-push","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/novartis-ms-drug-breakthrough-and-tiktoks-multi-gigawatt-compute-push\/73507\/","title":{"rendered":"Novartis MS Drug Breakthrough and TikTok\u2019s Multi-Gigawatt Compute Push"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_89 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"#\" data-href=\"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/novartis-ms-drug-breakthrough-and-tiktoks-multi-gigawatt-compute-push\/73507\/#Key_Takeaways\" >Key Takeaways<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"#\" data-href=\"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/novartis-ms-drug-breakthrough-and-tiktoks-multi-gigawatt-compute-push\/73507\/#Novartis_Achieves_Superior_Results_in_Phase_3_MS_Trials\" >Novartis Achieves Superior Results in Phase 3 MS Trials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"#\" data-href=\"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/novartis-ms-drug-breakthrough-and-tiktoks-multi-gigawatt-compute-push\/73507\/#TikTok_US_Targets_Massive_Compute_Expansion\" >TikTok U.S. Targets Massive Compute Expansion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"#\" data-href=\"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/novartis-ms-drug-breakthrough-and-tiktoks-multi-gigawatt-compute-push\/73507\/#Japan_Weighs_Defense_Rebranding_Amid_Trump_Pressure\" >Japan Weighs Defense Rebranding Amid Trump Pressure<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"#\" data-href=\"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/novartis-ms-drug-breakthrough-and-tiktoks-multi-gigawatt-compute-push\/73507\/#Geopolitical_Tensions_Iran_Strike_Paused_Russian_Evacuations\" >Geopolitical Tensions: Iran Strike Paused, Russian Evacuations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"#\" data-href=\"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/novartis-ms-drug-breakthrough-and-tiktoks-multi-gigawatt-compute-push\/73507\/#Market_Outlook_Mega-Cap_Earnings_Week_Ahead\" >Market Outlook: Mega-Cap Earnings Week Ahead<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Key_Takeaways\"><\/span>Key Takeaways<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Novartis (<a href=\"\/stock\/NVS\">NVS<\/a>)<\/strong> reported that its oral drug <strong>remibrutinib<\/strong> met all primary endpoints in Phase 3 trials, reducing the <strong>relapse rate by 35%<\/strong> in patients with relapsing multiple sclerosis (RMS) compared to existing treatments.<\/li>\n<li><strong>TikTok U.S.<\/strong> is reportedly scouting for <strong>four gigawatts<\/strong> of computing power by the early 2030s to support its domestic operations under its new joint venture structure.<\/li>\n<li><strong>Japan<\/strong> is considering a strategic rebranding of <strong>AI and energy<\/strong> investments as &quot;defense spending&quot; to meet U.S. pressure to increase military outlays toward <strong>3.5% of GDP<\/strong>.<\/li>\n<li><strong>President Trump<\/strong> confirmed the U.S. will not initiate military strikes against <strong>Iran<\/strong> before the November 3rd midterms, citing ongoing &quot;productive discussions&quot; despite a continued naval blockade.<\/li>\n<li><strong>Big Tech earnings<\/strong> dominate next week&#39;s calendar, with <a href=\"https:\/\/stockmarketwatch.com\/stock\/MSFT\" data-internallinksmanager029f6b8e52c=\"18\" title=\"Stock: MSFT\">Microsoft<\/a> (<a href=\"\/stock\/MSFT\">MSFT<\/a>), Alphabet (<a href=\"\/stock\/GOOGL\">GOOGL<\/a>), and Amazon (<a href=\"\/stock\/AMZN\">AMZN<\/a>) all scheduled to report results.<\/li>\n<\/ul>\n<hr>\n<h2><span class=\"ez-toc-section\" id=\"Novartis_Achieves_Superior_Results_in_Phase_3_MS_Trials\"><\/span>Novartis Achieves Superior Results in Phase 3 MS Trials<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Novartis (<a href=\"\/stock\/NVS\">NVS<\/a>) announced today that its highly selective oral BTK inhibitor, <strong>remibrutinib<\/strong>, successfully met its primary endpoints in the pivotal <strong>REMODEL-1<\/strong> and <strong>REMODEL-2<\/strong> Phase 3 trials. The drug demonstrated a <strong>35% reduction<\/strong> in the annualized relapse rate (ARR) compared to the standard-of-care treatment, teriflunomide.<\/p>\n<p>The clinical data also revealed a significant impact on disease progression, with <strong>92% of patients<\/strong> remaining free from progression at the six-month mark. Critically, the trials showed <strong>no liver safety signals<\/strong>, a major breakthrough for the BTK inhibitor class which has historically been plagued by toxicity concerns. Novartis (<a href=\"\/stock\/NVS\">NVS<\/a>) plans to seek global regulatory approval for the drug in RMS starting in 2027.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"TikTok_US_Targets_Massive_Compute_Expansion\"><\/span>TikTok U.S. Targets Massive Compute Expansion<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>TikTok\u2019s U.S. entity, <strong>TikTok USDS<\/strong>, is actively seeking to secure up to <strong>four gigawatts<\/strong> of computing capacity by the early 2030s, according to sources cited by CNBC. This massive infrastructure push follows the finalization of a deal earlier this year that transitioned TikTok\u2019s U.S. operations into a joint venture involving Oracle (<a href=\"\/stock\/ORCL\">ORCL<\/a>), <a href=\"https:\/\/stockmarketwatch.com\/metal\/silver\" data-internallinksmanager029f6b8e52c=\"5\" title=\"silver price today\">Silver<\/a> Lake, and MGX.<\/p>\n<p>The demand for &quot;multiple gigawatts&quot; underscores the platform&#39;s intensive data processing needs and its commitment to housing U.S. user data domestically. While Oracle (<a href=\"\/stock\/ORCL\">ORCL<\/a>) remains the primary cloud provider, the scale of this request suggests TikTok is preparing for a significant expansion of its <strong>AI-driven algorithm<\/strong> and content moderation capabilities.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Japan_Weighs_Defense_Rebranding_Amid_Trump_Pressure\"><\/span>Japan Weighs Defense Rebranding Amid Trump Pressure<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Japanese government is weighing a plan to reclassify spending on <strong>artificial intelligence, energy, and infrastructure<\/strong> as defense expenditures. This move comes as the administration of Prime Minister Sanae Takaichi faces pressure from the Trump administration to increase security spending toward a benchmark of <strong>3.5% of GDP<\/strong>.<\/p>\n<p>By including dual-use technologies like <strong>AI-driven surveillance<\/strong> and energy security projects, Japan aims to inflate its official defense outlays without further straining its heavily indebted public finances. The Nikkei reports that this rebranding could include investments in <strong>satellites, ports, and railways<\/strong> essential for military logistics.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Geopolitical_Tensions_Iran_Strike_Paused_Russian_Evacuations\"><\/span>Geopolitical Tensions: Iran Strike Paused, Russian Evacuations<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>President Trump stated on Thursday that the U.S. will refrain from attacking <strong>Iran<\/strong> before the upcoming midterm elections on November 3rd. While the President noted that a <strong>naval blockade<\/strong> remains in full effect, he emphasized that &quot;productive discussions&quot; are currently underway with Tehran to prevent the acquisition of nuclear weapons.<\/p>\n<p>Despite the pause in U.S. military action, flight-tracking data indicates a <strong>Russian Air Force TU-134<\/strong> recently departed Iran with its transponder off. Reports suggest the flight was used to evacuate high-ranking personnel and <strong>Russian scientists<\/strong> from the <strong>Bushehr Nuclear Power Plant<\/strong>, mirroring evacuation patterns seen prior to previous regional strikes.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Market_Outlook_Mega-Cap_Earnings_Week_Ahead\"><\/span>Market Outlook: Mega-Cap Earnings Week Ahead<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Investors are bracing for a high-stakes week as several of the world&#39;s largest companies prepare to release quarterly results. The schedule begins with Verizon (<a href=\"\/stock\/VZ\">VZ<\/a>) and Visa (<a href=\"\/stock\/V\">V<\/a>) on Monday and Tuesday, followed by the &quot;headliners&quot; on Wednesday: <a href=\"https:\/\/stockmarketwatch.com\/stock\/MSFT\" data-internallinksmanager029f6b8e52c=\"18\" title=\"Stock: MSFT\">Microsoft<\/a> (<a href=\"\/stock\/MSFT\">MSFT<\/a>) and Alphabet (<a href=\"\/stock\/GOOGL\">GOOGL<\/a>).<\/p>\n<p>Thursday will see reports from Amazon (<a href=\"\/stock\/AMZN\">AMZN<\/a>), Eli Lilly (<a href=\"\/stock\/LLY\">LLY<\/a>), and Intel (<a href=\"\/stock\/INTC\">INTC<\/a>), while the week concludes on Friday with energy giants ExxonMobil (<a href=\"\/stock\/XOM\">XOM<\/a>) and Chevron (<a href=\"\/stock\/CVX\">CVX<\/a>). Analysts will be particularly focused on <strong>AI capital expenditure<\/strong> guidance from the hyperscalers to gauge the sustainability of the current tech rally.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Novartis (NVS) reported that its oral drug remibrutinib met all primary endpoints in Phase 3 trials, reducing the [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[7316,33,9927,391,1485,1807,3768,5127,5230,5298,5318],"class_list":["post-73507","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-rms","tag-msft","tag-novartis-nvs-stock-nvs","tag-amzn","tag-arr","tag-earnings","tag-googl","tag-japan","tag-defense","tag-tiktok","tag-bytedance"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/73507","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=73507"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/73507\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=73507"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=73507"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=73507"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}